Target intelligence / Profile preview

Lipopolysaccharide in the outer membrane of Gram-negative bacteria (LPS)

Target
LPS
Molecular classification
Other (glycolipid), Microbial surface antigen, Major structural component of Gram-negative bacterial outer membrane
01

Overview

Lipopolysaccharide is a complex glycolipid forming the outer leaflet of the outer membrane of Gram-negative bacteria. It consists of three regions: lipid A (membrane anchor and endotoxin activity), core oligosaccharide (structural integrity), and O-antigen polysaccharide (serotype specificity and immune evasion). LPS is essential for bacterial survival, providing a protective barrier against toxic compounds, contributing to biofilm formation, and playing a key role as a pathogen-associated molecular pattern that triggers strong innate immune responses in host organisms. LPS is the principal cause of endotoxin-mediated clinical manifestations during Gram-negative infections, including sepsis and shock. Its diversity and capacity to evade immune responses present major challenges for therapy and diagnosis.

Other names
LipopolysaccharideLPSEndotoxin (when referring to its biological effects)Bacterial glycolipid
02

Mechanism of action

Drugs targeting LPS can disrupt outer membrane integrity, leading to increased permeability and bacterial death (e.g., colistin binds to lipid A, destabilizing the membrane). Blocking LPS recognition by host immune receptors (CD14/TLR4/MD2 complex), reducing proinflammatory cytokine release.

03

Biological functions

Maintains outer membrane integrityActs as a permeability barrier against harmful molecules, including antibiotics and bile saltsModulates host immune responsesElicits strong inflammatory/immune response (as endotoxin)Aids in biofilm formation and stabilityDetermines bacterial serotype (O-antigen diversity)
04

Disease associations

Infection (major virulence factor, immune system activation)Inflammation (endotoxin-induced sepsis, septic shock)Autoimmune/allergic disease associations (via immune system dysregulation)
05

Safety considerations

LPS is highly immunogenic and can induce dangerous systemic effects such as endotoxemia and septic shock.LPS structural diversity leads to challenges in broad-spectrum drug targeting and vaccine design.Drug resistance associated with LPS-modification (e.g., modified lipid A lowering drug binding).
06

Interacting drugs

Colistin (polymyxin E)

10 more in the full profile.

07

Biomarkers

O-antigen serotyping in clinical microbiology (diagnosis/classification)Detection of circulating LPS (endotoxin) as a marker of Gram-negative infection/sepsis

Beyond the preview

Go deeper on Lipopolysaccharide in the outer membrane of Gram-negative bacteria (LPS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lipopolysaccharide in the outer membrane of Gram-negative bacteria (LPS).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call